GlassScriptPhysician profile
Joseph B Carragher
NPI 1477988897
$7,614.64
in general payments reported to CMS, 2019-2025
42 companies · $1,099 in 2025
The $1,099 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,235 · 2020: $824 · 2021: $1,232 · 2022: $723 · 2023: $1,746 · 2024: $756 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,600.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $883.36 | 2019-2025 | Mitraclip, Diamondback Coronary, Navitor |
| Amgen INC. | $790.30 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $491.98 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $427.65 | 2019-2025 | Watchman Access System, Bodyguardian, Watchman Flx |
| Cardiovascular Systems INC. | $415.26 | 2019-2023 | Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $405.00 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $389.57 | 2020-2025 | Farxiga |
| Pfizer INC. | $387.27 | 2020-2025 | |
| Astellas Pharma US INC | $329.47 | 2020-2022 | |
| Endologix LLC | $305.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $255.25 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $238.69 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.38 | 2020-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.34 | 2020-2024 | Lifevest |
| Novo Nordisk INC | $150.61 | 2025 | Wegovy, Ozempic |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $149.27 | 2022-2025 | Camzyos |
| Medtronic, INC. | $143.08 | 2021-2025 | Hawkone, Protege Rx, In.Pact Admiral |
| Edwards Lifesciences Corporation | $140.13 | 2021-2024 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $137.08 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $134.35 | 2023-2025 | Impella |
| Osprey Medical INC | $127.00 | 2019 | |
| Esperion Therapeutics, INC. | $126.83 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $89.26 | 2023 | |
| Amarin Pharma, INC. | $89.22 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $80.38 | 2021-2025 | Uptravi, Opsumit |
| Medicure Pharma INC. | $74.05 | 2019 | |
| Alnylam Pharmaceuticals INC. | $51.16 | 2025 | Onpattro |
| Chiesi USA, INC. | $42.68 | 2020 | |
| Angiodynamics, INC. | $40.14 | 2024 | Auryon Laser System 100-120 Vac |
| Cvrx, INC. | $35.13 | 2025 | Barostim Neo System |
| Abbvie INC. | $32.08 | 2025 | |
| Terumo Medical Corporation | $30.36 | 2019 | |
| Scpharmaceuticals INC. | $25.23 | 2023 | |
| Reflow Medical INC | $24.23 | 2024 | |
| Stryker Corporation | $22.04 | 2025 | Clottriever Bold Catheter |
| Philips North America LLC | $19.10 | 2022 | |
| Innovation Technologies INC | $18.56 | 2021 | |
| Vital Connect, INC | $18.31 | 2023 | Vitalpatch Rtm |
| Biotronik INC. | $18.03 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.01 | 2025 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $17.53 | 2023 | Inpefa |
| Eisai INC. | $17.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Carragher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.